Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis

Chronic Diseases and Translational Medicine - Tập 7 - Trang 276-286 - 2021
Jin Feng1, Tianjiao Wei1, Xiaona Cui1, Rui Wei1, Tianpei Hong1
1Department of Endocrinology and Metabolism, Peking University Third Hospital, Beijing 100191, China

Tóm tắt

AbstractBackgroundThe global prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing. The pathogenesis of NAFLD is multifaceted, and the underlying mechanisms are elusive. We conducted data mining analysis to gain a better insight into the disease and to identify the hub genes associated with the progression of NAFLD.MethodsThe dataset GSE49541, containing the profile of 40 samples representing mild stages of NAFLD and 32 samples representing advanced stages of NAFLD, was acquired from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were identified using the R programming language. The Database for Annotation, Visualization and Integrated Discovery (DAVID) online tool and Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database were used to perform the enrichment analysis and construct protein–protein interaction (PPI) networks, respectively. Subsequently, transcription factor networks and key modules were identified. The hub genes were validated in a mice model of high fat diet (HFD)‐induced NAFLD and in cultured HepG2 cells by real‐time quantitative PCR.ResultsBased on the GSE49541 dataset, 57 DEGs were selected and enriched in chemokine activity and cellular component, including the extracellular region. Twelve transcription factors associated with DEGs were indicated from PPI analysis. Upregulated expression of five hub genes (SOX9, CCL20, CXCL1, CD24, and CHST4), which were identified from the dataset, was also observed in the livers of HFD‐induced NAFLD mice and in HepG2 cells exposed to palmitic acid or advanced glycation end products.ConclusionThe hub genes SOX9, CCL20, CXCL1, CD24, and CHST4 are involved in the aggravation of NAFLD. Our results offer new insights into the underlying mechanism of NAFLD progression.

Tài liệu tham khảo

10.1016/j.cld.2017.08.001 10.1146/annurev‐pathol‐012615‐044224 10.1007/s00125‐007‐0867‐x 10.1016/j.cmet.2013.10.004 10.1007/s00125‐016‐3902‐y 10.1038/s41591‐018‐0104‐9 10.4103/0975‐7406.100283 10.1210/jc.2009‐0212 10.1016/j.molmet.2015.12.004 10.1038/s41598‐018‐25658‐4 10.1002/hep.26661 10.3390/genes10080612 10.1111/jdi.12998 Gao S.B., 2017, Enhancing chemotherapy sensitivity by targeting PcG via the ATM/p53 pathway, Am J Canc Res, 7, 1874 10.1016/j.peptides.2019.170212 10.1136/gutjnl‐2020‐323082 10.1016/j.cmet.2020.11.010 10.1053/j.gastro.2010.09.038 10.5732/cjc.012.10151 10.1016/j.jhep.2019.09.014 10.1002/hep.28814 10.1172/JCI73722 10.1038/s41598‐018‐36037‐4 10.1172/JCI66022 10.1186/s13045‐020‐0845‐z 10.1158/1078‐0432.CCR‐19‐0098 10.1016/j.jare.2020.05.010 10.3390/cancers12102967 10.3389/fimmu.2020.01802 10.1136/gutjnl‐2013‐306098 10.1186/s12967‐018‐1490‐y 10.1016/j.aohep.2020.06.009 10.1007/s00109‐018‐1731‐9 10.1002/hep.21330 10.1152/ajplung.00300.2014 10.1038/ncb3581 10.1002/jcb.28456
Thông tin
Thông tin xuất bản

Chronic Diseases and Translational Medicine

Tập 7

276-286

Thông tin tác giả